SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
| Insider | Role | Date | Transaction | Shares | Value |
|---|---|---|---|---|---|
| Nelson Joshua B | Vice President | 2026-08-25 | Open-market sell | 10000 | $1.1M |
| Nelson Joshua B | Vice President | 2026-08-25 | Grant/award | 4 | $370 |
| DONNELLY WILLIAM P | Director | 2026-06-30 | Grant/award | 576 | $0 |
| MacLellan Robert F. | Director | 2026-06-30 | Grant/award | 658 | $0 |
| STEVENS ROBERT J | Director | 2026-06-30 | Grant/award | 537 | $0 |
| WILSON ALAN D | Director | 2026-06-30 | Grant/award | 691 | $0 |
| DONNELLY WILLIAM P | Director | 2026-06-29 | Grant/award | 142 | $16K |
| DUBLON DINA | Director | 2026-06-29 | Grant/award | 109 | $12K |
| Golston Allan C. | Director | 2026-06-29 | Grant/award | 55 | $6K |
| MacLellan Robert F. | Director | 2026-06-29 | Grant/award | 185 | $21K |
| STEVENS ROBERT J | Director | 2026-06-29 | Grant/award | 278 | $32K |
| Smith Cynthia F | Director | 2026-06-29 | Grant/award | 70 | $8K |
| Verma Richard R. | Director | 2026-06-29 | Grant/award | 55 | $6K |
| WIJNBERG SANDRA S | Director | 2026-06-29 | Grant/award | 148 | $17K |
| WILSON ALAN D | Director | 2026-06-29 | Grant/award | 462 | $53K |
| Page Sebastien | Vice President | 2026-06-01 | Grant/award | 96228 | $0 |
| Jackson Stephon A. | Vice President | 2026-05-13 | Grant/award | 175 | $17K |
| Jackson Stephon A. | Vice President | 2026-05-13 | Open-market sell | 3000 | $308K |
| BARTLETT MARK S. | Director | 2026-05-08 | Grant/award | 1899 | $0 |
| DONNELLY WILLIAM P | Director | 2026-05-08 | Grant/award | 1899 | $0 |
Fiscal period ending 2025-12-31 versus 2024-12-31 — view filing on EDGAR →
The risk profile shifted modestly net-worse, with three substantive new or escalated exposures — government shutdown operational impacts, AI-driven competitive displacement, and deregulation/regulatory divergence uncertainty — partially offset by the removal of seed capital impairment risk. The AI competitive threat is the most consequential addition, as it reframes technology risk from an operational/compliance issue to a structural business-model challenge. Regulatory risk is now pulling in two directions simultaneously, with both over-regulation and deregulation cited as sources of uncertainty and competitive disadvantage.
1 company-specific · 1 eased/removed · 2 common-mode
Added explicit competitive threat from AI-driven investment managers with lower-cost solutions and new operational control requirements, escalating business impact beyond prior regulatory/technical risks.
The recent advancements in and increased use of artificial intelligence (AI) present risks and challenges that may adversely impact our business. We or our third-party vendors, clients or…
Removal of seed capital/co-investment loss risk disclosure. Material easing if company no longer holds significant seed capital or has resolved prior impairment concerns.
Our financial condition and liquidity would be adversely affected by losses on our seed capital and co-investments. We have capital held in investment products we manage in a variety of asset…
New government shutdown risk added with specific operational impact: SEC approval delays for new products and market volatility effects.
RISKS RELATING TO OUR BUSINESS AND THE FINANCIAL SERVICES INDUSTRY. Our revenues are based on the market value and composition of the assets under our management, all of which are subject to…
New disclosure of deregulation risk and regulatory divergence creating uncertainty and potential competitive disadvantage. Substantive addition to prior year's compliance focus.
LEGAL AND REGULATORY RISKS. Compliance within a complex regulatory and legal environment which continues to evolve imposes significant financial and strategic costs on our business, and…
T. Rowe Price Group issued an earnings release on July 31, 2026 reporting results of operations for the three and six months ended June 30, 2026. The disclosure includes comprehensive financial highlights with diluted EPS of $2.88 (U.S. GAAP) and $2.57 (adjusted), AUM of $1.9 trillion, net client outflows of $6.5 billion, and detailed breakdowns of revenues, operating expenses, and non-operating income. This is a standard quarterly earnings release attached as Exhibit 99.1 and disclosed under Item 2.02.
View raw filing on EDGAR →